Nephrotic Syndrome for the internist

MJZ Ramirez, EJ Stein, K Jain - Medical Clinics, 2023 - medical.theclinics.com
Background Nephrotic syndrome (NS) is a disorder of the kidney that is defined by the
presence of greater than 3 to 3.5 g per day of proteinuria, which results in hypoalbuminemia …

Proximal tubule hypertrophy and hyperfunction: a novel pathophysiological feature in disease states

M Kanbay, S Copur, M Guldan, L Ozbek… - Clinical Kidney …, 2024 - academic.oup.com
The role of proximal tubules, a major component of the renal tubular structure located at the
renal cortex, in healthy and diseased states has been examined extensively. Along with its …

[HTML][HTML] Potential Underlying Mechanisms Explaining the Cardiorenal Benefits of Sodium–Glucose Cotransporter 2 Inhibitors

S Verma, S Mudaliar, PJ Greasley - Advances in Therapy, 2024 - Springer
There is a bidirectional pathophysiological interaction between the heart and the kidneys,
and prolonged physiological stress to the heart and/or the kidneys can cause adverse …

[HTML][HTML] Sodium-Glucose Co-Transporter 2 Inhibitors: Mechanism of Action and Efficacy in Non-Diabetic Kidney Disease from Bench to Bed-Side

AM Abdelrahman, AS Awad… - Journal of Clinical …, 2024 - mdpi.com
Sodium-glucose cotransporter 2 inhibitors (SGLT2i) are currently available for the
management of type 2 diabetes mellitus. SGLT2i acts by inhibiting renal SGLT2, thereby …

Drug repurposing for glomerular diseases: an underutilized resource

MSY Ng, G Kaur, RS Francis, CM Hawley… - Nature Reviews …, 2024 - nature.com
Drug repurposing in glomerular disease can deliver opportunities for steroid-free regimens,
enable personalized multi-target options for resistant or relapsing disease and enhance …

A novel risk factor for malignancy: albuminuria

M Kanbay, S Copur, ZY Yilmaz, C Tanriover… - European Journal of …, 2023 - Elsevier
Cancer is the second leading cause of death among the adult population following
cardiovascular diseases. Prevention and earlier diagnosis are among the cornerstones in …

Is there any robust evidence showing that SGLT2 inhibitor predisposes to cancer?

S Copur, AB Yildiz, A Covic… - European Journal of …, 2024 - Wiley Online Library
Background The exact pathophysiological mechanisms of SGLT‐2 inhibitors in the
development, progression or treatment of malignancies are not fully understood, but multiple …

[HTML][HTML] Risks and Benefits of SGLT-2 Inhibitors for Type 1 Diabetes Patients Using Automated Insulin Delivery Systems—A Literature Review

V Elian, V Popovici, O Karampelas… - International Journal of …, 2024 - mdpi.com
The primary treatment for autoimmune Diabetes Mellitus (Type 1 Diabetes Mellitus-T1DM) is
insulin therapy. Unfortunately, a multitude of clinical cases has demonstrated that the use of …

Apical tubular complement activation and the loss of kidney function in proteinuric kidney diseases

FF Alkaff, RGM Lammerts, MR Daha… - Clinical Kidney …, 2024 - academic.oup.com
Many kidney diseases are associated with proteinuria. Since proteinuria is independently
associated with kidney function loss, anti-proteinuric medication, often in combination with …

[HTML][HTML] An Updated Comprehensive Review on Diseases Associated with Nephrotic Syndromes

R Wendt, A Sobhani, P Diefenhardt, M Trappe… - Biomedicines, 2024 - mdpi.com
There have been exciting advances in our knowledge of primary glomerular diseases and
nephrotic syndromes in recent years. Beyond the histological pattern from renal biopsy …